PMID: 8955908Jan 1, 1996Paper

Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs

Biochimie
A DomiA Favre

Abstract

In order to study the activity of a hammerhead ribozyme in a cytoplasmic environment. HeLa cells infected with a recombinant vaccinia virus expressing T7 RNA polymerase were contransfected with plasmids expressing the ribozyme and its target RNA (nucleotides (nt) +1 to +692 of HIV-1 RNA) under the control of a T7 promoter. Two ribozyme-containing plasmids were designed to express RNAs of respectively 181 nt (Rz181) and 132 nt (Rz132). The sequence of each of these RNAs contained a 35 nt hammerhead ribozyme which is known to cleave its minimal 14-mer RNA substrate efficiently in vitro at a site corresponding to position +115 of the HIV-1 RNA. Control transfections were carried out with the parental plasmid pET3, which expressed a 134 nt RNA lacking the ribozyme sequence, and also with a plasmid expressing a 181 nt RNA (Rz181M) containing a single mutation known to inactivate the in vitro cleavage activity of the ribozyme. As detected by RT-PCR, the amount of target RNA was reproducibly reduced at a ribozyme/target ratio higher than 50 with Rz181 and Rz132 whereas it remained unaffected with Rz181M, thus eliminating the possibility of antisense inhibition. Rz132 proved to be more efficient than Rz181. Competitive RT-PCR indicated...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J O OjwangJ Rappaport
Jan 1, 1992·Advances in Experimental Medicine and Biology·J J Rossi, N Sarver
Nov 27, 1990·Biochemistry·D E RuffnerO C Uhlenbeck
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D Herschlag
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M Sioud, K Drlica
Mar 9, 1990·Science·N SarverJ J Rossi
Jan 1, 1990·Methods in Enzymology·F W StudierJ W Dubendorff
Aug 13, 1987·Nature·O C Uhlenbeck
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·F H Cameron, P A Jennings
Jul 25, 1989·Nucleic Acids Research·C C Sheldon, R H Symons
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T R FuerstB Moss
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Nov 1, 1993·Trends in Genetics : TIG·K P FoleyJ D Engel
Feb 11, 1994·Nucleic Acids Research·E BertrandT Grange
May 1, 1994·Current Biology : CB·J J Rossi
Jun 25, 1995·Nucleic Acids Research·O HeidenreichM Nerenberg
Feb 1, 1995·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·M KiehntopfF Herrmann
Oct 1, 1993·Science·Z TsuchihashiD Herschlag
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·L Q SunG Symonds
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·K J ScanlonM Kashani-Sabet
Jun 25, 1994·Nucleic Acids Research·R B DenmanD L Miller
Sep 15, 1994·Biochemical and Biophysical Research Communications·M VenturaS Saragosti
Jun 10, 1994·Journal of Molecular Biology·A WoisardA Favre
Nov 11, 1993·Nucleic Acids Research·J Ellis, J Rogers
Nov 11, 1993·Nucleic Acids Research·P CrisellW James
May 11, 1993·Nucleic Acids Research·B DropulićK T Jeang
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·J T RasmussenM L Vetter
Mar 28, 1986·Science·G A ProdyG Bruening

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.